Abstract:Purpose: USP has formed Advisory Panels to ensure the integrity of laboratory procedures for non-oral routes of administration and expects that the panels will recommend performance tests (performance qualification, PQ) for these dosage forms as well as performance verification tests (PVT) for those PQ tests. An integral part of PQ is PVT, in which a standard formulation is first tested in a metrologically sound collaborative study to set acceptance criteria. Individual laboratories can then test the performance of their product by comparing their results to those obtained from the USP collaborative study. These studies are guided by metrological principles, e.g., those of the International Organization for Standardization (ISO) 43-1, which succinctly states that "one of the main uses of proficiency testing schemes is to assess laboratories' ability to perform tests competently." Materials and methods: Four laboratories conducted two collaborative studies to determine the reliability and reproducibility--understood in metrological terms--of release rates from semisolid dosage forms using the vertical diffusion cell (VDC). Results: The experiments reported here from the second study found that the major contributor to variability is the interlaboratory component that may include intermediate precision considerations other than analyst. Because all laboratories used the same model equipment, one might expect that the observed reproducibility CV was lower than if the laboratories used different models or equipment made by different manufacturers. Also, more variability was observed with the creams than the other dosage forms. Conclusions: The results from the preliminary collaborative study found inconsistency among the laboratories. After operator training, the results from the second study were more consistent, suggesting the initial results were associated with variations among the laboratories in performing the methods and procedures and conducting the protocols. Those results emphasize that although the in vitro release procedure is simple and reproducible, training is needed. The data presented suggest that testing of in vitro release by VDCs should be considered as a PVT for topical semisolid dosage forms. Thus, a standard semisolid product is needed, along with a means for setting acceptance criteria. The SUPAC-SS Guidance may be helpful in the latter regard.

Drug Release Test to Assess Quality of Topical Formulations in Japanese Market

Release Characterization of Drugs in Hot-melt Pressure Sensitive Adhesive

Drug-release Assessment of Compounded Topical Nifedipine and Diltiazem in Commonly Used Bases for Wound Healing

Accelerated In-Vitro Release Testing Methods for Extended-Release Parenteral Dosage Forms

Application of the Analytical Procedure Lifecycle Concept to a Quantitative 1H NMR Method for Total Dammarane-Type Saponins.

Strategizing Spray Drying Process Optimization for the Manufacture of Redispersible Indomethacin Nanoparticles Using Quality-by-Design Principles

A Method for Measuring the Surface Free Energy of Topical Semi-solid Dosage Forms

An Analytical Target Profile for the Development of an In Vitro Release Test Method and Apparatus Selection in the Case of Semisolid Topical Formulations

Reliability and reproducibility of vertical diffusion cells for determining release rates from semisolid dosage forms

Quality Risk Management and Quality by Design for the Development of Diclofenac Sodium Intra-articular Gelatin Microspheres

Release Profiles of Dexamethasone Dipropionate from Admixtures of Steroid and Heparinoid Ointments Prepared by Different Mixing Methods

Generic Development of Topical Dermatologic Products: Formulation Development, Process Development, and Testing of Topical Dermatologic Products

Indicator-based assessment of potential supply risks for pharmaceutical excipients: Method and application

Analysis of Factors Related to Variation in Dissolution Profiles Estimated from Continuously Conducted Dissolution Tests of Generic Products

Preparation of N,N- Diethyl-M-toluamide Sustained Release Cream and Study Its Percutaneous Permeability in Vitro

Method Development for Simultaneously Determining Indomethacin and Nicotinamide in New Combination in Oral Dosage Formulations and Co-Amorphous Systems Using Three UV Spectrophotometric Techniques

In Vitro Evaluation of a Foamable Microemulsion Towards an Improved Topical Delivery of Diclofenac Sodium

Improvement of Dissolution Test Method for Nimodipine Tablets and Comparison of Different Samples

Tissue Distribution and Dermal Drug Determination of Indomethacin Transdermal-Absorption Patches

Skin permeability of tulobuterol in two transdermal formulations and their followability

The Implications of Regulatory Framework for Topical Semisolid Drug Products: From Critical Quality and Performance Attributes towards Establishing Bioequivalence